| EMA number | EMEA/H/C/002437 |
| ATC code | M05BA08 |
| Authorisation | 15 August 2012 |
| Withdrawn | 18 January 2018 |
| Revision | 11 |
Treatment of osteoporosis: in post-menopausal women; in men; at increased risk of fracture including those with a recent low-trauma hip fracture. Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: in post-menopausal women; in men; at increased risk of fracture. Treatment of Paget’s disease of the bone in adults.